PD Dr. rer. nat. habil. Julia Brenmoehl
Research interests
- Control of fat and energy metabolism, cell signalling
Curriculum Vitae
- 2009: Research Institute for Farm Animal Biology (FBN)
- 2007–2009: University Hospital Jena, Internal Medicine IV, Department for Gastroenterology, Hepatology und Infectiology
- 2005–2007: Graduation (Dr. rer. nat.)
- 2003–2004: Postgraduate studies in subject biology, University Regensburg; qualification receipt for graduation
- 2002–2006: University Hospital Regensburg, Department of Gastroenterology, Endocrinology, Rheumatology, Infectiology, Emergency Medicine
- 2002: University Hospital Rostock, Internal Medicine, Department of Gastroenterology
- 2001–2001: Creatogen AG Augsburg, Department: Vaccines
- 1997–2002: Biotechnology studies, university of applied science Jena
- 1997: Diploma from German secondary school qualifying for university admission or matriculation
Publications
Brenmoehl, J.; Herfarth, H.; Gluck, T.; Audebert, F.; Barlage, S.; Schmitz, G.; Froehlich, D.; Schreiber, S.; Hampe, J.; Scholmerich, J.; Holler, E.; Rogler, G. (2007):
Genetic variants in the NOD2/CARD15 gene are associated with early mortality in sepsis patients. Intensive Care Med 33: 1541-1548
Rieder, F.; Brenmoehl, J.; Leeb, S.; Scholmerich, J.; Rogler, G. (2007):
Wound healing and fibrosis in intestinal disease. Gut 56: 130-139
Holler, E.; Rogler, G.; Brenmoehl, J.; Hahn, J.; Herfarth, H.; Greinix, H.; Dickinson, A. M.; Socie, G.; Wolff, D.; Fischer, G.; Jackson, G.; Rocha, V.; Steiner, B.; Eissner, G.; Marienhagen, J.; Schoelmerich, J.; Andreesen, R. (2006):
Prognostic significance of NOD2/CARD15 variants in HLA-identical sibling hematopoietic stem cell transplantation: effect on long-term outcome is confirmed in 2 independent cohorts and may be modulated by the type of gastrointestinal decontamination. Blood 107: 4189-4193
Wolff, D.; Roessler, V.; Steiner, B.; Wilhelm, S.; Weirich, V.; Brenmoehl, J.; Leithaeuser, M.; Hofmeister, N.; Junghanss, C.; Casper, J.; Hartung, G.; Holler, E.; Freund, M. (2005):
Treatment of steroid-resistant acute graft-versus-host disease with daclizumab and etanercept. Bone Marrow Transplant. 35: 1003-1010
Holler, E.; Rogler, G.; Herfarth, H.; Brenmoehl, J.; Wild, P. J.; Hahn, J.; Eissner, G.; Scholmerich, J.; Andreesen, R. (2004):
Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation. Blood 104: 889-894